Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
VEGFA overexpression
i
Other names:
VEGFA, Vascular endothelial growth factor A, VEGF, Vascular Endothelial Growth Factor A121, Vascular Endothelial Growth Factor A165, Vascular Endothelial Growth Factor, VEGF-A, MVCD1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7422
Related biomarkers:
Expression
Mutation
Others
‹
VEGFA expression (2)
VEGFA expression + FLT1 expression + KDR expression (1)
VEGFA expression (2)
VEGFA expression + FLT1 expression + KDR expression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
VEGFA overexpression
Squamous Cell Carcinoma of Head and Neck
VEGFA overexpression
Squamous Cell Carcinoma of Head and Neck
cisplatin + 5-fluorouracil
Sensitive: C3 – Early Trials
cisplatin + 5-fluorouracil
Sensitive
:
C3
cisplatin + 5-fluorouracil
Sensitive: C3 – Early Trials
cisplatin + 5-fluorouracil
Sensitive
:
C3
VEGFA overexpression
Colorectal Cancer
VEGFA overexpression
Colorectal Cancer
EGFR inhibitor
Resistant: C3 – Early Trials
EGFR inhibitor
Resistant
:
C3
EGFR inhibitor
Resistant: C3 – Early Trials
EGFR inhibitor
Resistant
:
C3
VEGFA overexpression
Small Intestinal Carcinoma
VEGFA overexpression
Small Intestinal Carcinoma
bevacizumab
Sensitive: C3 – Early Trials
bevacizumab
Sensitive
:
C3
bevacizumab
Sensitive: C3 – Early Trials
bevacizumab
Sensitive
:
C3
VEGFA overexpression
HER2 Positive Breast Cancer
VEGFA overexpression
HER2 Positive Breast Cancer
pyrotinib
Sensitive: C3 – Early Trials
pyrotinib
Sensitive
:
C3
pyrotinib
Sensitive: C3 – Early Trials
pyrotinib
Sensitive
:
C3
VEGFA overexpression
Gastric Cancer
VEGFA overexpression
Gastric Cancer
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
VEGFA overexpression
Glioblastoma
VEGFA overexpression
Glioblastoma
bevacizumab
Resistant: D – Preclinical
bevacizumab
Resistant
:
D
bevacizumab
Resistant: D – Preclinical
bevacizumab
Resistant
:
D
VEGFA overexpression
Renal Cell Carcinoma
VEGFA overexpression
Renal Cell Carcinoma
sunitinib
Sensitive: D – Preclinical
sunitinib
Sensitive
:
D
sunitinib
Sensitive: D – Preclinical
sunitinib
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login